Stemness CD24 activation promotes hepatocellular carcinoma progression via an immune escape mechanism

Figure 1 Comparative analysis of serum clusters of differentiation 24 expression among patients with chronic liver diseases. A: Clusters of differentiation (CD) 24 expression in the serum of patients with chronic hepatitis (CH), liver cirrhosis (LC), or hepatocellular carcinoma (HCC) or healthy individuals; B: Alpha-fetoprotein expression in the serum of patients with CH, LC, or HCC or healthy individuals; C: Receiver operating characteristic curve of circulating CD24 for the diagnosis of HCC patients; D: Survival curves of circulating CD24 levels in HCC patients generated by the Kaplan-Meier method. The green line represents the high CD24 group, and the blue line represents the low CD24 group. CH: Chronic hepatitis; LC: Liver cirrhosis; HCC: Hepatocellular carcinoma; AFP: Alpha-fetoprotein; ROC: Receiver operating characteristic; CD: Clusters of differentiation; NC: Normal control.